A detailed history of First Community Trust Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Community Trust Na holds 285 shares of GILD stock, worth $25,102. This represents 0.02% of its overall portfolio holdings.

Number of Shares
285
Previous 285 -0.0%
Holding current value
$25,102
Previous $19,000 21.05%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $6,284 - $6,856
-85 Reduced 22.97%
285 $21,000
Q1 2023

Apr 06, 2023

SELL
$77.31 - $88.08 $7,731 - $8,808
-100 Reduced 21.28%
370 $30,000
Q3 2022

Oct 14, 2022

SELL
$59.54 - $68.01 $1,190 - $1,360
-20 Reduced 4.08%
470 $29,000
Q1 2022

Apr 06, 2022

BUY
$57.92 - $72.58 $1,158 - $1,451
20 Added 4.26%
490 $29,000
Q4 2021

Feb 16, 2022

BUY
$64.88 - $73.64 $30,493 - $34,610
470 New
470 $34,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track First Community Trust Na Portfolio

Follow First Community Trust Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Community Trust Na, based on Form 13F filings with the SEC.

News

Stay updated on First Community Trust Na with notifications on news.